6-MAPB

Source: Wikipedia, the free encyclopedia.
6-MAPB
Legal status
Legal status
Identifiers
  • 1-(Benzofuran-6-yl)-N-methylpropan-2-amine
JSmol)
  • CC(NC)CC1=CC(OC=C2)=C2C=C1
  • InChI=1S/C12H15NO/c1-9(13-2)7-10-3-4-11-5-6-14-12(11)8-10/h3-6,8-9,13H,7H2,1-2H3
  • Key:QLAAURQYEAEHBO-UHFFFAOYSA-N

6-MAPB (1-(benzofuran-6-yl)-N-methylpropan-2-amine) is a psychedelic and entactogenic drug which is structurally related to 6-APB and MDMA.[1][2][3][4] It is not known to have been widely sold as a "designer drug" but has been detected in analytical samples taken from individuals hospitalised after using drug combinations that included other benzofuran derivatives.[citation needed] 6-MAPB was banned in the UK in June 2013, along with 9 other related compounds which were thought to produce similar effects.[5]

References

This page is based on the copyrighted Wikipedia article: 6-MAPB. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy